Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Arrand

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Journal of Virology|July 25, 2000
Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNAS N Stacey, D Jordan, A J Williamson, et al.
European Journal of Immunology|December 1, 1994
Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoproteinJ S Bartholomew, S N Stacey, B Coles, et al.
Journal of Virology|October 1, 1994
Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110)J P Stewart, N J Janjua, N P Sunil-Chandra, et al.
Journal of Medical Virology|June 1, 1988
Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cottontop tamarins against EB virus-induced malignant lymphomasA J Morgan, M Mackett, S Finerty, et al.
The New England Journal of Medicine|June 8, 1989
Human herpesvirus 6 infection in renal-transplant recipientsD J Morris, E Littler, J R Arrand, et al.
The Journal of General Virology|February 1, 1992
Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vectorS Finerty, J Tarlton, M Mackett, et al.
International Journal of Cancer|March 27, 2001
Antibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinomaY Connolly, E Littler, N Sun, et al.
Virology|August 1, 1993
The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and BJ F Lees, J E Arrand, S D Pepper, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patientsJ P Stewart, A T McGown, J Prendiville, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1975
Cleavage maps of DNA from adenovirus types 2 and 5 by restriction endonucleases EcoRI and HpaIC Mulder, J R Arrand, H Delius, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Journal of Virology|July 25, 2000
Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNAS N Stacey, D Jordan, A J Williamson, et al.
European Journal of Immunology|December 1, 1994
Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoproteinJ S Bartholomew, S N Stacey, B Coles, et al.
Journal of Virology|October 1, 1994
Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110)J P Stewart, N J Janjua, N P Sunil-Chandra, et al.
Journal of Medical Virology|June 1, 1988
Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cottontop tamarins against EB virus-induced malignant lymphomasA J Morgan, M Mackett, S Finerty, et al.
The New England Journal of Medicine|June 8, 1989
Human herpesvirus 6 infection in renal-transplant recipientsD J Morris, E Littler, J R Arrand, et al.
The Journal of General Virology|February 1, 1992
Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vectorS Finerty, J Tarlton, M Mackett, et al.
International Journal of Cancer|March 27, 2001
Antibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinomaY Connolly, E Littler, N Sun, et al.
Virology|August 1, 1993
The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and BJ F Lees, J E Arrand, S D Pepper, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patientsJ P Stewart, A T McGown, J Prendiville, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1975
Cleavage maps of DNA from adenovirus types 2 and 5 by restriction endonucleases EcoRI and HpaIC Mulder, J R Arrand, H Delius, et al.
Pageof 9